• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4640408)   Today's Articles (203)   Subscriber (50362)
For: Barry J, Kirby B. Novel biologic therapies for psoriasis. Expert Opin Biol Ther 2005;4:975-87. [PMID: 15174979 DOI: 10.1517/14712598.4.6.975] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Number Cited by Other Article(s)
1
Arai T, Ohno M, Inoue H, Hayashi S, Aoki T, Hirokawa H, Meguro H, Koga Y, Oshida K, Kainoh M, Suyama K, Kawai H. Design and synthesis of novel p38α MAP kinase inhibitors: discovery of pyrazole-benzyl ureas bearing 2-molpholinopyrimidine moiety. Bioorg Med Chem Lett 2012;22:5118-22. [PMID: 22749282 DOI: 10.1016/j.bmcl.2012.05.095] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2012] [Revised: 05/22/2012] [Accepted: 05/28/2012] [Indexed: 10/28/2022]
2
Iwano S, Asaoka Y, Akiyama H, Takizawa S, Nobumasa H, Hashimoto H, Miyamoto Y. A possible mechanism for hepatotoxicity induced by BIRB-796, an orally active p38 mitogen-activated protein kinase inhibitor. J Appl Toxicol 2011;31:671-7. [PMID: 21328587 DOI: 10.1002/jat.1622] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2010] [Revised: 10/18/2010] [Accepted: 10/19/2010] [Indexed: 11/08/2022]
3
Optimization of α-ketoamide based p38 inhibitors through modifications to the region that binds to the allosteric site. Bioorg Med Chem Lett 2010;20:4819-24. [DOI: 10.1016/j.bmcl.2010.06.102] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2010] [Revised: 06/14/2010] [Accepted: 06/21/2010] [Indexed: 11/20/2022]
4
BAKULEV AL, KRAVCHENYA SS, SLESARENKO NA, SHABOGINA AA. Efficacy and safety of treatment of patients suffering from severe forms of psoriasis. VESTNIK DERMATOLOGII I VENEROLOGII 2010. [DOI: 10.25208/vdv934] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]  Open
5
Discovery and characterization of the N-phenyl-N′-naphthylurea class of p38 kinase inhibitors. Bioorg Med Chem Lett 2009;19:2386-91. [DOI: 10.1016/j.bmcl.2009.03.104] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2009] [Revised: 03/20/2009] [Accepted: 03/23/2009] [Indexed: 11/19/2022]
6
Gutiérrez M, Ruiz Carrascosa JC. [The lymphocyte: protagonism in the new era of the biological therapies]. ACTAS DERMO-SIFILIOGRAFICAS 2008;99 Suppl 1:2-8. [PMID: 18341848 DOI: 10.1016/s0001-7310(08)76193-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]  Open
7
Dugger KJ, Zinn KR, Weaver C, Bullard DC, Barnum SR. Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis. J Neuroimmunol 2008;206:22-7. [PMID: 19010554 DOI: 10.1016/j.jneuroim.2008.10.006] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2008] [Accepted: 10/14/2008] [Indexed: 01/10/2023]
8
Cogan D, Aungst R, Breinlinger E, Fadra T, Goldberg D, Hao M, Kroe R, Moss N, Pargellis C, Qian K, Swinamer A. Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase. Bioorg Med Chem Lett 2008;18:3251-5. [DOI: 10.1016/j.bmcl.2008.04.043] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2008] [Revised: 04/15/2008] [Accepted: 04/21/2008] [Indexed: 11/30/2022]
9
Krell J, Nelson C, Spencer L, Miller S. An open-label study evaluating the efficacy and tolerability of alefacept for the treatment of scalp psoriasis. J Am Acad Dermatol 2008;58:609-16. [DOI: 10.1016/j.jaad.2007.12.031] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2007] [Revised: 11/02/2007] [Accepted: 12/20/2007] [Indexed: 01/03/2023]
10
Synthesis and SAR studies of indole-based MK2 inhibitors. Bioorg Med Chem Lett 2008;18:1994-9. [PMID: 18291646 DOI: 10.1016/j.bmcl.2008.01.119] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2007] [Revised: 01/26/2008] [Accepted: 01/29/2008] [Indexed: 01/02/2023]
11
Moss N, Breitfelder S, Betageri R, Cirillo PF, Fadra T, Hickey ER, Kirrane T, Kroe RR, Madwed J, Nelson RM, Pargellis CA, Qian KC, Regan J, Swinamer A, Torcellini C. New modifications to the area of pyrazole-naphthyl urea based p38 MAP kinase inhibitors that bind to the adenine/ATP site. Bioorg Med Chem Lett 2007;17:4242-7. [PMID: 17560108 DOI: 10.1016/j.bmcl.2007.05.042] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2007] [Revised: 05/10/2007] [Accepted: 05/11/2007] [Indexed: 11/22/2022]
12
Hammach A, Barbosa A, Gaenzler FC, Fadra T, Goldberg D, Hao MH, Kroe RR, Liu P, Qian KC, Ralph M, Sarko C, Soleymanzadeh F, Moss N. Discovery and design of benzimidazolone based inhibitors of p38 MAP kinase. Bioorg Med Chem Lett 2006;16:6316-20. [PMID: 17010605 DOI: 10.1016/j.bmcl.2006.09.014] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2006] [Revised: 08/31/2006] [Accepted: 09/06/2006] [Indexed: 11/28/2022]
13
Gamo R, López-Estebaranz JL. Terapia biológica y psoriasis. ACTAS DERMO-SIFILIOGRAFICAS 2006;97:1-17. [PMID: 16540046 DOI: 10.1016/s0001-7310(06)73342-7] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]  Open
14
Kaspar RL. Challenges in developing therapies for rare diseases including pachyonychia congenita. J Investig Dermatol Symp Proc 2005;10:62-6. [PMID: 16250210 DOI: 10.1111/j.1087-0024.2005.10208.x] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
15
Gilchrest BA, Eller MS. DNA photodamage stimulates melanogenesis and other photoprotective responses. J Investig Dermatol Symp Proc 1999;4:35-40. [PMID: 10537005 DOI: 10.1038/sj.jidsp.5640178] [Citation(s) in RCA: 129] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA